A new model that predicts visible recurrence after endoscopic eradication of Barrett’s oesophagus with dysplasia or early cancer can help establish a personalised follow-up strategy for patients, researchers say.

The prognostic model, which has been externally validated, was built using data from adults in the Dutch Barrett Expert Center Registry who underwent endoscopic treatment.

“Once complete Barrett’s eradication is achieved, the chances for neoplastic recurrence are so small that we significantly reduce the burden of endoscopic follow-up procedures in the vast majority of cases,” said senior author and gastroenterologist Dr Jacques Bergman.

“Those with an increased risk can be identified with our prediction model,” added Dr Bergman, from the Amsterdam University Medical Center.